News

2023.07.07
The M&A process runs in parallel with research and development activities

2023.05.30
Genomtec at BIO International Convention

2023.05.12
Interview with Miron Tokarski, CEO of Genomtec S.A. at Gazeta Giełdy i Inwestorów „Parkiet”

2023.04.27
Genomtec S.A. will raise PLN 13.1 million from share issue

2023.03.29
Presentation - Genomtec's development plans and the status of the M&A process

Archive

2023.07.07

The M&A process runs in parallel with research and development activities

– We are concentrating our efforts on multiple areas that are directly linked to the Genomtec ID platform. Our main focus lies in ...
Read
2023.05.30

Genomtec at BIO International Convention

We are pleased to announce that Genomtec team (Miron Tokarski & Charudutt Shah) will attend BIO 2023 from Jun 5-8, 2023 in Boston. ...
Read
2023.05.12

Interview with Miron Tokarski, CEO of Genomtec S.A. at Gazeta Giełdy i Inwestorów „Parkiet”

Key interview subjects: – Funds raised from the share issue will impact the realization of milestones and increase the value of ...
Read
2023.04.27

Genomtec S.A. will raise PLN 13.1 million from share issue

Funds will increase the value of the Company’s technology in M&A transaction. More informtaion: ...
Read
2023.03.29

Presentation – Genomtec’s development plans and the status of the M&A process

We invite you to watch the webinar and chat with Genomtec’s Management Board, which took place on Strefa Inwestorów on Wednesday, March 29. ...
Read
2023.03.22

Webinar with the Management Board of Genomtec

A webinar with Genomtec Management Board organized by the Warsaw Stock Exchange will be held on Friday, March 24, at 4:00 pm. Link to the ...
Read

Archive